In this study, although the serum HER2/ neu levels of the patients with NMIBC were noted to be similar to those of the control group, the urinary HER2/neu levels and urinary HER2/neu level/urinary creatinine ratio were significantly higher in patients with bladder cancer. This evidence concerns the gene ERBB2 and urinary bladder carcinoma.